Keck School Faculty

Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels J Genet Couns. 2023 Feb 06. . View in PubMed

ASO Visual Abstract: Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients Ann Surg Oncol. 2022 Nov 01. . View in PubMed

ASO Author Reflections: A Green Light for Genetic Testing in All Patients with Breast Cancer Ann Surg Oncol. 2022 Oct 14. . View in PubMed

Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients Ann Surg Oncol. 2022 Sep 26. . View in PubMed

Transcriptome analysis provides critical answers to the "variants of uncertain significance" conundrum Hum Mutat. 2022 11; 43(11):1590-1608. . View in PubMed

Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes Mol Genet Genomic Med. 2022 10; 10(10):e2031. . View in PubMed

Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients Cancer. 2021 04 15; 127(8):1275-1285. . View in PubMed

Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells Gynecol Oncol. 2020 12; 159(3):869-876. . View in PubMed

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D J Natl Cancer Inst. 2020 12 14; 112(12):1242-1250. . View in PubMed

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families J Clin Oncol. 2020 03 01; 38(7):674-685. . View in PubMed

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk JCO Precis Oncol. 2019 Mar; 3. . View in PubMed

Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry J Natl Cancer Inst. 2018 10 01; 110(10):1059-1066. . View in PubMed

Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices NPJ Genom Med. 2018; 3:7. . View in PubMed

Patient communication of cancer genetic test results in a diverse population Transl Behav Med. 2018 01 29; 8(1):85-94. . View in PubMed

Unexpected CDH1 Mutations Identified on Multigene Panels Pose Clinical Management Challenges JCO Precis Oncol. 2017 Nov; 1:1-12. . View in PubMed

Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort Cancer Genet. 2016 Apr; 209(4):130-7. . View in PubMed

A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer Cancer Genet. 2016 Mar; 209(3):75-81. . View in PubMed

Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings Genet Test Mol Biomarkers. 2015 Dec; 19(12):657-65. . View in PubMed

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress Clin Genet. 2013 Nov; 84(5):464-72. . View in PubMed

Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions Mol Diagn Ther. 2013 Feb; 17(1):31-47. . View in PubMed

Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs J Cancer Educ. 2012 Jun; 27(3):467-77. . View in PubMed

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors J Genet Couns. 2012 Apr; 21(2):151-61. . View in PubMed

Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce Genet Med. 2011 Sep; 13(9):832-40. . View in PubMed

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine CA Cancer J Clin. 2011 Sep-Oct; 61(5):327-59. . View in PubMed

Development and evaluation of a decision aid for BRCA carriers with breast cancer J Genet Couns. 2011 Jun; 20(3):294-307. . View in PubMed

Recurrence and variability of germline EPCAM deletions in Lynch syndrome Hum Mutat. 2011 Apr; 32(4):407-14. . View in PubMed

Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates Patient Educ Couns. 2011 Apr; 83(1):92-8. . View in PubMed

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study Lancet Oncol. 2011 Jan; 12(1):49-55. . View in PubMed

Breast cancer risk communication: assessment of primary care physicians by standardized patients Genet Med. 2009 Oct; 11(10):735-41. . View in PubMed

Genetic assessment of breast cancer risk in primary care practice Am J Med Genet A. 2009 Mar; 149A(3):349-56. . View in PubMed

Limited family structure and BRCA gene mutation status in single cases of breast cancer JAMA. 2007 Jun 20; 297(23):2587-95. . View in PubMed

Results of a randomized study of telephone versus in-person breast cancer risk counseling Patient Educ Couns. 2006 Dec; 64(1-3):96-103. . View in PubMed

Effects of counseling Ashkenazi Jewish women about breast cancer risk Cultur Divers Ethnic Minor Psychol. 2006 Jan; 12(1):45-56. . View in PubMed

Assessing breast cancer risk and BRCA1/2 carrier probability Breast Dis. 2006-2007; 27:5-20. . View in PubMed

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors J Genet Couns. 2004 Apr; 13(2):83-114. . View in PubMed

Oncologists' opinions on genetic testing for breast and ovarian cancer Genet Med. 2001 Mar-Apr; 3(2):120-5. . View in PubMed

Genetic counseling for women with an intermediate family history of breast cancer Am J Med Genet. 2000 Feb 28; 90(5):361-8. . View in PubMed